Hide Board Information

Show Board Information

Westell Technologies WSTL

Board Mod: Serial Investor

Asst Mods:

Last Post: 08/14/2020 3:55:46 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Westell Technologies (NASDAQ: WSTL) Stock Message Board

1. WSTL Company Profile

    

2. WSTL Time & Sales

    

3. WSTL Recent News

    

4. WSTL Filings

    

5. WSTL Financials

    

6. WSTL Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	$WSTL News Article - CORRECTING and REPLACING -	whytestocks	08/14/2020 3:55:46 PM
9	$WSTL News Article - Westell Introduces Public	whytestocks	07/15/2020 12:25:48 PM
8	$WSTL News Article - Westell Reports Fiscal 2020	whytestocks	06/17/2020 4:05:40 PM
7	$WSTL News Article - Westell Launches RMX-4000	whytestocks	06/11/2019 4:30:40 PM
6	10% .15M C3.46 after hour vol looks	znewcar1	05/23/2018 5:00:27 PM
5	WSTL Stock year to date has changed -9.33%	Jake13	02/11/2015 7:51:01 AM
4	WSTL 1.36 Westell Technologies Stock Charts $WSTL	chartguy89	02/11/2015 6:59:08 AM
3	Latest Westell Technologies (WSTL) Headlines	Stock_Tracker	03/13/2014 3:56:53 PM
2	WSTL Stock Charts Last: +0.07 Sunday, March 2,	chartguy89	03/02/2014 12:24:55 AM
1	WSTL Stock Charts Last: -0.01 Friday, February	chartguy89	02/28/2014 7:56:24 AM

Recent Articles

• Clinical Breakthrough: ITM's Promising Trial Results Unveiled
• Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
• New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
• Concerns Raised Over Elon Musk's Striking Compensation Package
• Qustodio: Elevating Digital Child Safety on iPhones in 2025
• Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
• Innovative Gedatolisib and Darolutamide Study Shows Promise
• New Insights on Gedatolisib's Role in Breast Cancer Treatment
• Meta and Blue Owl Collaborate on $30 Billion AI Data Center
• Kura Oncology's Latest Insights on FTI Program Advancements
• Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
• Kura Oncology Unveils Promising Data from FTI Programs at ESMO
• Olema Oncology Shares Promising Findings on Palazestrant
• General Oncology's SHARON Trial Yields Encouraging Results
• Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
• Corbus Pharmaceuticals Reports Promising Results for CRB-701
• Promising Data on NX-1607: A Breakthrough in Cancer Treatment
• Florida Cancer Specialists Revolutionizing Oncology Research
• Salesforce CEO's Apology Sparks Controversy in Tech Industry
• Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
• Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
• Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
• Trump's Decision on Ukraine Missiles Revealed After Key Talks
• Kevin O'Leary Highlights Importance of American Dream for Leadership
• Transformational Program for Millennial Professionals Unveiled
• Investigation Launched as PeopleGuru Faces Data Breach Crisis
• Trump Seeks Supreme Court Approval for National Guard in Chicago
• Westhaven Gold Corp. Announces Executive Update and Future Plans
• Trump Commutes Santos' Prison Sentence Amid Public Support
• A New Toolkit to Enhance Executive Function Skills in Education
• Westhaven Gold Announces Leadership Changes and Operations Update
• Aeroméxico's Exciting Global Offering: What You Need to Know
• Investigation Into Luminar Technologies Signals Serious Concerns
• Inquiry into Hasbro Leadership: Legal Investigation Unfolds
• Legal Investigation of CVS/Aetna Medicare Advantage Claims
• Deadline Approaches for Dow Investors in Class Action Case
• Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
• Fluor Corporation Lawsuit Update: Important Investor Info
• Investors Urged to Act Before KBR Class Action Deadline
• Cytokinetics Class Action Lawsuit Update: Important Deadlines
• Important Legal Update for WPP Investors: Key Deadline Approaches
• Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
• Marex Group Faces Class Action Lawsuit Over Financial Misconduct
• Lead the Charge: Join the Fly-E Group Securities Lawsuit
• Investigation into MoonLake Immunotherapeutics Raises Concerns
• MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
• Investigation of MoonLake Immunotherapeutics Raises Concerns
• Leadership Changes at Silver Mountain Resources: What to Expect
• Canton Fair Launches Enhanced Services to Boost Global Trade
• rYojbaba's Global Outreach: Enhancing Health and Legal Aid Services